Nick Plummer
General Counsel bei VOLITIONRX LIMITED
Profil
Nick Plummer is currently the Group General Counsel at VolitionRX Ltd.
Prior to this, he worked as the Managing Counsel-Europe at Patheon France SAS from 2013 to 2021.
He also worked as the Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008 and at Novacyt SAS as the Secretary & General Counsel.
Additionally, he worked at Ashurst Morris Crisp from 2004 to 2007.
Aktive Positionen von Nick Plummer
| Unternehmen | Position | Beginn |
|---|---|---|
| VOLITIONRX LIMITED | General Counsel | 01.11.2021 |
Ehemalige bekannte Positionen von Nick Plummer
| Unternehmen | Position | Ende |
|---|---|---|
Patheon France SAS
 Patheon France SAS Pharmaceuticals: MajorHealth Technology Patheon France SAS provides drug development and manufacturing services. The company is headquartered in Bourgoin-Jallieu, France. | Corporate Officer/Principal | 01.01.2021 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | General Counsel | 01.01.2008 |
| NOVACYT | General Counsel | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVACYT | Health Technology |
| VOLITIONRX LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Patheon France SAS provides drug development and manufacturing services. The company is headquartered in Bourgoin-Jallieu, France. | Health Technology |
